Randomized Trial of Beta-Carotene and Macular Degeneration

NCT00000152 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

NIH

Sponsor class

Conditions

Macular Degeneration

Interventions

DRUG: Aspirin
DRUG: Beta-Carotene

Sponsor

National Eye Institute (NEI)